FOMO is supported by the financial results that company have published in the Quarterly Appendix 4C and Annual Report.
Yes the honest opinion about the company is whether you are seeing more growth (revenue / profit / defence industry) rather than overreacting to directors selling shares.
It also seems like that the shares were loaned to these directors also, repayment money goes back to the company.![]()
- Forums
- ASX - By Stock
- DRO
- Ann: Change of Director's Interest Notice
Ann: Change of Director's Interest Notice, page-68
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DRO (ASX) to my watchlist
|
|||||
Last
$2.60 |
Change
0.260(11.1%) |
Mkt cap ! $1.982B |
Open | High | Low | Value | Volume |
$2.41 | $2.60 | $2.41 | $48.35M | 19.18M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5505 | $2.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.60 | 98988 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5505 | 2.590 |
7 | 59449 | 2.580 |
5 | 9470 | 2.570 |
6 | 64001 | 2.560 |
15 | 216295 | 2.550 |
Price($) | Vol. | No. |
---|---|---|
2.600 | 98905 | 25 |
2.610 | 39183 | 6 |
2.620 | 121287 | 5 |
2.630 | 9612 | 3 |
2.640 | 1000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
DRO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online